+1 915 229 3004 (U.S.) | 
+44 7452 242832 (U.K.)
+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)
Global Magnetic Beads Market Size was valued at USD 3.6 Billion in 2022. The Magnetic Beads market industry is projected to grow from USD 3.9 Billion in 2023 to USD 9.2 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 12.50% during the forecast period (2023 - 2032). The usage of molecular biology has expanded quickly due to its dependability, ease of use, and minimal processing needs as well as the growing demand for healthcare solutions are the key market drivers enhancing the market growth.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
Because of their dependability, minimal processing demands, and simplicity, molecular biology applications are being used more and more frequently. The market is expected to be stimulated by its growing application in the purification of many biomolecules, including mitochondrial DNA, genomic plasmids, DNA, and RNA. The demand for in-vitro diagnostics facilities, clinical research labs, antibody test labs, and labs for generating vaccines has increased as a result of the worldwide COVID-19 outbreak. Since those who have any chronic disease, such as cancer or renal issues, are more susceptible to get the virus, there has been an increase in the testing and treatment of blood samples from patients with chronic diseases. Additionally, it is anticipated that this will boost the use of magnetic beads, which will have an impact on market expansion.
As the demand for healthcare products rises, the market for magnetic beads is anticipated to expand rapidly. For instance, in-vitro diagnostics are more accepted due to their simplicity of use, speed of results, and direct-to-consumer testing. Additionally, due to the growing popularity of point-of-care (POC) outside of the laboratory or at the doorstep, it is anticipated that the widespread spread of chronic diseases and the growing population will increase the utilization of magnetic beads.
In the coming years, it is also projected that favorable government laws and policies in the US will hasten the market expansion for magnetic beads. For instance, in vitro devices are referred to as biological products in both section 201(h) of the Federal Food, Drug, and Cosmetic Act and section 351, the Public Health Service Act. In addition, it is anticipated that the U.S. will see an increase in healthcare spending as a result of technological developments in medicine, rising costs for medical supplies, and greater demand for medical services due to an aging population.
Magnetic beads are a great material to use in a variety of nanomedicine applications because of their different physicochemical properties compared to bulk materials. Treatments using nanomagnetic fields and radio-frequency induction have become available as a result of technological developments in the medical field. The need for medical applications is predicted to increase as a result of these treatments. Therefore, it is anticipated that increasing utilization of nanomaterials in tumor treatment will hasten market growth. Due to continuing research and development efforts over the past several years, the market for magnetic beads has a ton of space for growth. The market is anticipated to be driven by the increasing popularity of magnetic beads and their multiple applications in fields including genetic research, diagnostics, and pharmaceuticals. Thus, driving the Magnetic Beads market revenue.
The global Magnetic Beads market segmentation, based on Application, includes bioresearch, in-vitro diagnostics, and others. In-vitro diagnostics held the largest market share in 2022. This is because more bio-separation processes for a particular cell or molecule type are using magnetic beads. The market is expected to increase as a result of the increasing need for cellular research among researchers and pharmaceutical firms to comprehend the physiological and chemical mechanisms included within molecules. The growth of the industry has led to an increase in research spending and investments by the pharmaceutical and life sciences industries. The demand for blood sample tests has increased due to the increasing prevalence of infectious diseases like HIV and the Zika virus, which is fostering the expansion of magnetic beads.
By improving the effectiveness of cell separation and isolation approaches, magnetic beads present a suitable alternative that has the potential to change a variety of biological research fields. It is also anticipated that the product will advance quickly in the field of biological research due to the optimization of key laboratory processes like biomolecule isolation, enzyme-linked immunosorbent assays (ELISA), and polymerase chain reactions (PCR) for making copies of DNA samples. The market for magnetic beads is expected to grow significantly over the course of the projected period as a result of these developments.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
By region, Insights into the markets in North America, Europe, Asia-Pacific, and the rest of the world are provided by the study. The North America Magnetic Beads Market dominated this market in 2022 (45.80%). Regional development has been supported by the ongoing exploration of possible nanotechnology applications in numerous end-use industries. The increased focus on using magnetic beads for drug administration and other biological applications is predicted to positively impact market growth over the course of the expected year.
Demand is expected to rise in the upcoming years as a result of the expansion of the bioresearch industries in the US and Canada. Several strategic partnerships and agreements are helping to advance bioresearch in Canada. The healthcare industry is expected to grow even more throughout the forecast period as a result of favorable government laws, which will increase demand for magnetic beads. Further, In the North American area, the U.S. Magnetic Beads Market market had the biggest market share, while the Canada Magnetic Beads Market market had the quickest rate of expansion.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
Europe Magnetic Beads market accounts for the significant market share. This is a result of the expanding demand for therapeutic and diagnostic solutions to address the global health concerns that are becoming more and more serious. Due to the region's rising prevalence of infectious diseases, mental health issues, and COVID-19, there is an increased need for healthcare facilities and the diagnostics centers that go along with them. Further, In the European region, the German Magnetic Beads market had the biggest market share, and the U.K. Magnetic Beads market had the quickest rate of growth.
The Asia Pacific Magnetic Beads market is expected to register fastest growth from 2023 to 2032. This is a result of how swiftly the healthcare and diagnostics industries are growing in China and Japan. due to alluring government policies, increasing medical industry investment, and other factors. The demand for magnetic beads in the region is expected to rise as a result of the region's increasing need for advanced diagnostic technologies due to the prevalence of chronic diseases. Moreover, In the Asia-Pacific region, the Indian Magnetic Beads market had the quickest rate of growth while China's Magnetic Beads Market market had the greatest market share.
Leading industry companies are making significant R&D investments in order to diversify their product offerings, which will drive the Magnetic Beads Market market's expansion. Important market developments include new product releases, contractual agreements, mergers and acquisitions, greater investments, and collaboration with other organizations. Market participants are also engaging in a number of strategic actions to increase their global footprint. The Magnetic Beads Market sector needs to provide affordable products if it wants to grow and thrive in a more competitive and challenging market environment.
One of the primary business strategies employed by manufacturers in the worldwide Aerospace Foam industry to assist customers and expand the market sector is local manufacturing to reduce operational costs. Some of the biggest benefits to medicine have recently come from the Magnetic Beads Market sector. Major players in the Magnetic Beads market, including Thermo Fisher Scientific Inc., Merck KGaA, Bangs Laboratories Inc., Spherotech, Inc, GenScript, CardioGenics Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec, Ferrotec (USA) Corporation, Eurofins Technologies, Micromod Partikeltechnologie GmbH, New England Biolabs, Rockland Immunochemicals, Inc., and MagQu Co. Ltd, are attempting to increase market demand by investing in research and development operations.
Next-generation sequencing (NGS) and multiomics technologies are developed by Singular Genomics Systems Inc (Singular Genomics), a life science technology business. The state of California houses its U.S. headquarters. The G4 operating system and New England Biolabs' NEBNext Kits, a product used to gather DNA and RNA samples, were validated in January 2022 by a partnership between the two companies. NEBNext kits are developed and quality-controlled to increase yields and library richness using a wide range of input volumes from a wide range of sample types.
Induced pluripotent stem (iPS) cells are used by Fujifilm Cellular Dynamics, Inc. to develop and produce physiologically appropriate human cells. The company's donor-specific, industrial-scale MyCell® and iCell® solutions are incredibly pure, remarkably repeatable, and allow for stem cell banking, drug discovery, toxicity testing, and the creation of cell treatments. To enhance the creation of cutting-edge drug discovery tests, Promega Corporation and FUJIFILM Cellular Dynamics, Inc. partnered in March 2022. According to the multi-year license agreement, scientists and researchers may use induced pluripotent stem cell functionalities that are specially differentiating from Promega Biosensor and intracellular bioluminescent reporter capabilities as part of innovative assay development in the drug development process.
· Thermo Fisher Scientific Inc.
· Merck KGaA
· Bangs Laboratories Inc.
· Spherotech, Inc
· GenScript
· CardioGenics Inc.
· Bio-Rad Laboratories, Inc.
· Miltenyi Biotec
· Ferrotec (USA) Corporation
· Eurofins Technologies
· Micromod Partikeltechnologie GmbH
· New England Biolabs
· Rockland Immunochemicals, Inc.
· MagQu Co. Ltd
February 2022: The Magnetic Nano Particles Developer's Kit is a set of products made by Ferrotec Corporation for the production of microbeads used in in-vitro diagnostic applications. Ferrotec's MNP solutions improve reactivity, accuracy, and specificity for IVD applications such immunoassays, bio-separations, and molecular testing since they have the ability to considerably increase microbead surface area.
· Bioresearch
· In-vitro Diagnostics
· Others
· North America
- US
- Canada
· Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
· Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
· Rest of the World
- Middle East
- Africa
- Latin America
Report Scope
|
Report Attribute/Metric |
Details |
|
Market Size 2022 |
USD 3.6 Billion |
|
Market Size 2023 |
USD 3.9 Billion |
|
Market Size 2032 |
USD 9.2 Billion |
|
Compound Annual Growth Rate (CAGR) |
12.50% (2023-2032) |
|
Base Year |
2022 |
|
Market Forecast Period |
2023-2032 |
|
Historical Data |
2018- 2022 |
|
Market Forecast Units |
Value (USD Billion) |
|
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
|
Segments Covered |
Application, and Region |
|
Geographies Covered |
North America, Europe, Asia Pacific, and the Rest of the World |
|
Countries Covered |
The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
|
Key Companies Profiled |
Thermo Fisher Scientific Inc., Merck KGaA, Bangs Laboratories Inc., Spherotech, Inc, GenScript, CardioGenics Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec, Ferrotec (USA) Corporation, Eurofins Technologies, Micromod Partikeltechnologie GmbH, New England Biolabs, Rockland Immunochemicals, Inc., and MagQu Co. Ltd |
|
Key Market Opportunities |
Growing popularity of magnetic beads |
|
Key Market Dynamics |
Rapid growth in molecular biology applications owing to their easy-to-use property, minimal processing requirement, and reliability and the increasing demand for healthcare products |
The global Magnetic Beads Market was valued at USD 3.6 billion in 2022, and it is estimated to reach USD 9.2 billion by 2032.
The global market is projected to grow at a CAGR of 12.50% during the forecast period, 2023-2032.
North America had the largest share in the global market.
The key players in the market are Thermo Fisher Scientific Inc., Merck KGaA, Bangs Laboratories Inc., Spherotech, Inc, GenScript, CardioGenics Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec, Ferrotec (USA) Corporation, Eurofins Technologies, Micromod Partikeltechnologie GmbH, New England Biolabs, Rockland Immunochemicals, Inc., and MagQu Co. Ltd
The In-vitro Diagnostics Application dominated the market in 2022.
Report Code :
RL6587
Published on :
Aug 2023
Request a Free Sample Report
Speak to Analyst